Health Trials

Magnetic Resonance Imaging (MRI)-Guided Rectal Cancer Preservation Program

ConditionRectal Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorClinica Universidad de Navarra, Universidad de Navarra

About this trial

The goal of this clinical trial is to learn if the use of MRI-guided irradiation increases the rates of rectal preservation

Eligibility criteria

Qualifiers

Patients aged 18 or older with primary Stage II (T3-4, N0) or Stage III (any T, N1-2) biopsy-proven rectal cancer

No prior radiation therapy to the target areas;

Absolute neutrophil count (ANC) ≥ 1,000 cells/mm3

Platelets ≥ 50,000 cells/mm3.

Disqualifiers

Patient unable to undergo an MRI examination

Trial design

Treatments tested in this trial

  • MR-Guided Irradiation

Treatment groups

32 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Clinica Universidad de Navarra, Universidad de Navarra

Lead sponsor

Source ClinicalTrials.gov